Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction

Michel White, Kanan Patel, Guillem Caldentey, Prakash Deedwania, Raya Kheirbek, Ross D. Fletcher, Inmaculada B. Aban, Alexander Lo, Wilbert S. Aronow, Gregg C. Fonarow, Stefan D. Anker, Ali Ahmed

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In Beta-Blocker Evaluation of Survival Trial (BEST) bucindolol significantly reduced mortality among Caucasians with systolic heart failure (HF) but not among African Americans. Whether this differential effect can be explained by racial differences in baseline characteristics has not been previously examined. Of the 2708 BEST participants, 627 were African Americans. Because African Americans were more likely to be younger and women, we used age-sex-adjusted hazard ratios (HR) and 95% confidence intervals (CI) to estimate their outcomes (vs. Caucasians). A step-wise multivariable-adjusted model using 24 baseline characteristics was used to identify variables associated with between-race outcome differences and propensity-matching was used to determine independence of associations. Age-sex-adjusted HR for all-cause mortality for African Americans during 2 years of mean follow-up was 1.27. African Americans were more likely to have lower right ventricular ejection fraction. African Americans had no association with mortality among propensity-matched patients. The higher risk of death among African Americans in BEST may in part be due to their lower RVEF which may in part explain the lack of response to bucindolol among these patients. Future studies need to examine the role of low RVEF on the effect of beta-blockers in patients with systolic HF.

Original languageEnglish
Pages (from-to)255-260
Number of pages6
JournalInternational Journal of Cardiology
Volume177
Issue number1
DOIs
Publication statusPublished - Nov 15 2014

Fingerprint

Systolic Heart Failure
African Americans
Stroke Volume
Mortality
Survival
Confidence Intervals

Keywords

  • Ejection fraction
  • Heart failure
  • Mortality
  • Race

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Racial differences in mortality in patients with advanced systolic heart failure : Potential role of right ventricular ejection fraction. / White, Michel; Patel, Kanan; Caldentey, Guillem; Deedwania, Prakash; Kheirbek, Raya; Fletcher, Ross D.; Aban, Inmaculada B.; Lo, Alexander; Aronow, Wilbert S.; Fonarow, Gregg C.; Anker, Stefan D.; Ahmed, Ali.

In: International Journal of Cardiology, Vol. 177, No. 1, 15.11.2014, p. 255-260.

Research output: Contribution to journalArticle

White, M, Patel, K, Caldentey, G, Deedwania, P, Kheirbek, R, Fletcher, RD, Aban, IB, Lo, A, Aronow, WS, Fonarow, GC, Anker, SD & Ahmed, A 2014, 'Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction', International Journal of Cardiology, vol. 177, no. 1, pp. 255-260. https://doi.org/10.1016/j.ijcard.2014.09.094
White, Michel ; Patel, Kanan ; Caldentey, Guillem ; Deedwania, Prakash ; Kheirbek, Raya ; Fletcher, Ross D. ; Aban, Inmaculada B. ; Lo, Alexander ; Aronow, Wilbert S. ; Fonarow, Gregg C. ; Anker, Stefan D. ; Ahmed, Ali. / Racial differences in mortality in patients with advanced systolic heart failure : Potential role of right ventricular ejection fraction. In: International Journal of Cardiology. 2014 ; Vol. 177, No. 1. pp. 255-260.
@article{637bf6b96d394de2bb59d2dd0750d39f,
title = "Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction",
abstract = "In Beta-Blocker Evaluation of Survival Trial (BEST) bucindolol significantly reduced mortality among Caucasians with systolic heart failure (HF) but not among African Americans. Whether this differential effect can be explained by racial differences in baseline characteristics has not been previously examined. Of the 2708 BEST participants, 627 were African Americans. Because African Americans were more likely to be younger and women, we used age-sex-adjusted hazard ratios (HR) and 95{\%} confidence intervals (CI) to estimate their outcomes (vs. Caucasians). A step-wise multivariable-adjusted model using 24 baseline characteristics was used to identify variables associated with between-race outcome differences and propensity-matching was used to determine independence of associations. Age-sex-adjusted HR for all-cause mortality for African Americans during 2 years of mean follow-up was 1.27. African Americans were more likely to have lower right ventricular ejection fraction. African Americans had no association with mortality among propensity-matched patients. The higher risk of death among African Americans in BEST may in part be due to their lower RVEF which may in part explain the lack of response to bucindolol among these patients. Future studies need to examine the role of low RVEF on the effect of beta-blockers in patients with systolic HF.",
keywords = "Ejection fraction, Heart failure, Mortality, Race",
author = "Michel White and Kanan Patel and Guillem Caldentey and Prakash Deedwania and Raya Kheirbek and Fletcher, {Ross D.} and Aban, {Inmaculada B.} and Alexander Lo and Aronow, {Wilbert S.} and Fonarow, {Gregg C.} and Anker, {Stefan D.} and Ali Ahmed",
year = "2014",
month = "11",
day = "15",
doi = "10.1016/j.ijcard.2014.09.094",
language = "English",
volume = "177",
pages = "255--260",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Racial differences in mortality in patients with advanced systolic heart failure

T2 - Potential role of right ventricular ejection fraction

AU - White, Michel

AU - Patel, Kanan

AU - Caldentey, Guillem

AU - Deedwania, Prakash

AU - Kheirbek, Raya

AU - Fletcher, Ross D.

AU - Aban, Inmaculada B.

AU - Lo, Alexander

AU - Aronow, Wilbert S.

AU - Fonarow, Gregg C.

AU - Anker, Stefan D.

AU - Ahmed, Ali

PY - 2014/11/15

Y1 - 2014/11/15

N2 - In Beta-Blocker Evaluation of Survival Trial (BEST) bucindolol significantly reduced mortality among Caucasians with systolic heart failure (HF) but not among African Americans. Whether this differential effect can be explained by racial differences in baseline characteristics has not been previously examined. Of the 2708 BEST participants, 627 were African Americans. Because African Americans were more likely to be younger and women, we used age-sex-adjusted hazard ratios (HR) and 95% confidence intervals (CI) to estimate their outcomes (vs. Caucasians). A step-wise multivariable-adjusted model using 24 baseline characteristics was used to identify variables associated with between-race outcome differences and propensity-matching was used to determine independence of associations. Age-sex-adjusted HR for all-cause mortality for African Americans during 2 years of mean follow-up was 1.27. African Americans were more likely to have lower right ventricular ejection fraction. African Americans had no association with mortality among propensity-matched patients. The higher risk of death among African Americans in BEST may in part be due to their lower RVEF which may in part explain the lack of response to bucindolol among these patients. Future studies need to examine the role of low RVEF on the effect of beta-blockers in patients with systolic HF.

AB - In Beta-Blocker Evaluation of Survival Trial (BEST) bucindolol significantly reduced mortality among Caucasians with systolic heart failure (HF) but not among African Americans. Whether this differential effect can be explained by racial differences in baseline characteristics has not been previously examined. Of the 2708 BEST participants, 627 were African Americans. Because African Americans were more likely to be younger and women, we used age-sex-adjusted hazard ratios (HR) and 95% confidence intervals (CI) to estimate their outcomes (vs. Caucasians). A step-wise multivariable-adjusted model using 24 baseline characteristics was used to identify variables associated with between-race outcome differences and propensity-matching was used to determine independence of associations. Age-sex-adjusted HR for all-cause mortality for African Americans during 2 years of mean follow-up was 1.27. African Americans were more likely to have lower right ventricular ejection fraction. African Americans had no association with mortality among propensity-matched patients. The higher risk of death among African Americans in BEST may in part be due to their lower RVEF which may in part explain the lack of response to bucindolol among these patients. Future studies need to examine the role of low RVEF on the effect of beta-blockers in patients with systolic HF.

KW - Ejection fraction

KW - Heart failure

KW - Mortality

KW - Race

UR - http://www.scopus.com/inward/record.url?scp=84909953142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909953142&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2014.09.094

DO - 10.1016/j.ijcard.2014.09.094

M3 - Article

C2 - 25499389

AN - SCOPUS:84909953142

VL - 177

SP - 255

EP - 260

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -